Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome
NCT07498998Not yet recruiting
- Sponsor
- Tanta University
- Start
- Jul 2026
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands, Inhalation Devices
- Countries
- 1
01
Overview
Trial of dextrose, medical ozonated water and dexamethasone in carpal tunnel syndrome (CTS) (3 arms), sponsored by Tanta University. Primary endpoints: Median Nerve Distal Motor Latency at 3 months and Median Nerve Sensory Conduction Velocity at 3 months. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
dextrosemedical ozonated waterdexamethasone
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT07498998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07498998.